InventionMed S.A. (WSE:INM)

Market Cap	22.61M -43.3%
Revenue (ttm)	2.28M +1,305.9%
Net Income	-2.52M
EPS	-0.01
Shares Out	202.79M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,161
Open	0.1125
Previous Close	0.1125
Day's Range	0.1105 - 0.1135
52-Week Range	0.0972 - 0.2060
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. The company flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. It also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. The company was incorporated in 2012 and is based in Bydgoszcz, Poland.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 4
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: INM

Financial Performance

In 2024, InventionMed's revenue was 277,760, an increase of 45810.74% compared to the previous year's 605. Losses were -4.41 million, 133.2% more than in 2023.